Compounds > imipramine

imipramine and kainic acid

imipramine has been researched along with kainic acid in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (60.00)18.2507
2000's1 (20.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bauer, C; Caldwell, L; Kinnier, WJ; Lancaster, J; McMillan, B; Price, CH; Sweetnam, PM1
Bartoccini, F; Carminati, P; Castorina, M; Di Cesare, MA; Di Serio, S; Gallo, G; Ghirardi, O; Giorgi, F; Giorgi, L; Minetti, P; Piersanti, G; Tarzia, G; Tinti, MO1
Hayashi, S; Kato, A; Mizuno, K; Morita, A; Nakata, E; Ohashi, K; Yamamura, K1
Ho, IK; McCaslin, PP; Smith, TG; Yu, XZ1
Fujii, T1

Reviews

1 review(s) available for imipramine and kainic acid

ArticleYear
The role of receptor binding in drug discovery.
    Journal of natural products, 1993, Volume: 56, Issue:4

    Topics: Animals; Drug Design; Humans; Receptors, Drug

1993

Other Studies

4 other study(ies) available for imipramine and kainic acid

ArticleYear
2-n-Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine and analogues as A2A adenosine receptor antagonists. Design, synthesis, and pharmacological characterization.
    Journal of medicinal chemistry, 2005, Nov-03, Volume: 48, Issue:22

    Topics: Adenine; Adenosine A2 Receptor Antagonists; Animals; Cell Line; Cricetinae; Cricetulus; Drug Design; Humans; Imidazoles; Male; Models, Molecular; Motor Activity; Purines; Radioligand Assay; Rats; Rats, Inbred F344; Structure-Activity Relationship; Triazoles

2005
Discovery of {1-[4-(2-{hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl}-1H-benzimidazol-1-yl)piperidin-1-yl]cyclooctyl}methanol, systemically potent novel non-peptide agonist of nociceptin/orphanin FQ receptor as analgesic for the treatment of neuropathic pain: de
    Bioorganic & medicinal chemistry, 2010, Nov-01, Volume: 18, Issue:21

    Topics: Analgesics; Animals; Benzimidazoles; Drug Design; Drug Evaluation, Preclinical; Humans; Microsomes, Liver; Neuralgia; Nociceptin Receptor; Pyrroles; Rats; Receptors, Opioid; Structure-Activity Relationship

2010
Amitriptyline prevents N-methyl-D-aspartate (NMDA)-induced toxicity, does not prevent NMDA-induced elevations of extracellular glutamate, but augments kainate-induced elevations of glutamate.
    Journal of neurochemistry, 1992, Volume: 59, Issue:2

    Topics: Amitriptyline; Animals; Cell Death; Cells, Cultured; Extracellular Matrix; Glutamates; Imipramine; Kainic Acid; Lethal Dose 50; N-Methylaspartate; Neurons; Nortriptyline; Quisqualic Acid; Rats; Rats, Inbred Strains; Taurine

1992
Transgenerational effects of maternal exposure to chemicals on the functional development of the brain in the offspring.
    Cancer causes & control : CCC, 1997, Volume: 8, Issue:3

    Topics: Aggression; Aminobutyrates; Animals; Anticonvulsants; Antidepressive Agents, Tricyclic; Antineoplastic Agents; Antipsychotic Agents; Behavior, Animal; Brain; Chlorpromazine; Cisplatin; Embryonic and Fetal Development; Emotions; Enzyme Inhibitors; Ethosuximide; Excitatory Amino Acid Agonists; Female; Fever; Gestational Age; Glutamate-Ammonia Ligase; Herbicides; Hippocampus; Hypothermia; Imipramine; Kainic Acid; Male; Maternal Exposure; Nimustine; Pregnancy; Prenatal Exposure Delayed Effects; Psychotropic Drugs; Rats; Rats, Inbred Strains; Rats, Wistar; Risk Assessment

1997